Additionally, Thiel et al. (2013) found that EZH2 acts alongside menin to epigenetically suppress the expression of pro-differentiation C/EBPα target genes and block the mature differentiation of MLL-AF9+ leukemia cells. This evidence concerns the gene KMT2A and leukemia.